SCHEMBL698008

SCHEMBL698008

C=C(C)C(=O)NCCOc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.71
MTNR1B P49286 2/20 0.71
L3MBTL1 Q9Y468 1/20 0.64
RAB9A P51151 6/20 0.59
NPC1 O15118 5/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
HPGD P15428 2/20 0.59
ALDH1A1 P00352 1/20 0.56
RECQL P46063 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPT P10636 2/20 0.56
POLB P06746 1/20 0.54
CASP3 P42574 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
USP2 O75604 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19617577 0.95 L3MBTL1 (0.71) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10362456 0.91 L3MBTL1 (0.65) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10363166 0.89 L3MBTL1 (0.63) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10362652 0.89 L3MBTL1 (0.63) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10364005 0.89 L3MBTL1 (0.63) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10362325 0.89 L3MBTL1 (0.63) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10362391 0.89 L3MBTL1 (0.63) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10364020 0.89 L3MBTL1 (0.63) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10362350 0.89 L3MBTL1 (0.63) MTNR1AMTNR1BL3MBTL1RAB9ANPC1
SCHEMBL10803028 0.89 L3MBTL1 (0.63) MTNR1AMTNR1BL3MBTL1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250032398-A1 HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2025-01-30 US disclosed
EP-3246367-B1 AQUEOUS INK, INK CARTRIDGE, AND INK JET RECORDING METHOD CANON KK (JP) 2024-04-10 EP disclosed
US-20230303746-A1 PHOTOCURABLE COMPOSITION, DENTURE BASE, AND PLATE DENTURE MITSUI CHEMICALS, INC. (JP) 2023-09-28 US disclosed
US-20230151133-A1 COMPOSITION COMPRISING STYRENE ISOBUTYLENE BLOCK COPOLYMER AND ETHYLENICALLY UNSATURATED MONOMER 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-05-18 US disclosed
US-20190382519-A1 CROSS-LINKED BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES, COMPOSITIONS, AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2019-12-19 US disclosed
US-10125284-B2 Aqueous ink, ink cartridge, and ink jet recording method CANON KABUSHIKI KAISHA (JP) 2018-11-13 US disclosed
WO-2018132548-A1 CROSS-LINKED BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES, COMPOSITIONS, AND APPLICATIONS THEREOF ISP INVESTMENTS LLC (US) 2018-07-19 WO disclosed
US-20170335125-A1 AQUEOUS INK, INK CARTRIDGE, AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2017-11-23 US disclosed
EP-3246367-A1 AQUEOUS INK, INK CARTRIDGE, AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2017-11-22 EP disclosed
US-8641182-B2 Ink jet ink, ink cartridge, and ink jet recording method CANON KABUSHIKI KAISHA (JP) 2014-02-04 US disclosed
US-8529045-B2 Ink set and image forming method FUJIFILM CORPORATION (JP) 2013-09-10 US disclosed
US-8529045-B2 Ink set and image forming method FUJIFILM CORPORATION (JP) 2013-09-10 US disclosed
US-8439495-B2 Ink jet liquid composition, set, liquid cartridge, and ink jet recording method CANON KABUSHIKI KAISHA (JP) 2013-05-14 US disclosed
US-20120050391-A1 INK JET LIQUID COMPOSITION, SET, LIQUID CARTRIDGE, AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2012-03-01 US disclosed
US-20120050384-A1 INK JET INK, INK CARTRIDGE, AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2012-03-01 US disclosed
EP-2423273-A1 Ink jet ink containing an ABC triblock copolymer Canon Kabushiki Kaisha (JP) 2012-02-29 EP disclosed
EP-2423271-A1 Ink jet liquid composition, set, liquid cartridge, and ink jet recording method Canon Kabushiki Kaisha (JP) 2012-02-29 EP disclosed
US-20110057987-A1 INK SET AND IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2011-03-10 US disclosed
US-20110057987-A1 INK SET AND IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120050391-A1 INK JET LIQUID COMPOSITION, SET, LIQUID CARTRIDGE, AND INK JET RECORDING METHOD MITF, KATNAL2, RB1 MTNR1A 3123/4885MTNR1B 1308/4885L3MBTL1 272/4885
US-20190382519-A1 CROSS-LINKED BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES, COMPOSITIONS, AND APPLICATIONS THEREOF ADSL, ABHD6, APH1B MTNR1A 4792/4885MTNR1B 4681/4885L3MBTL1 2380/4885
US-20250032398-A1 HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF PCNA, ADSL, APH1B MTNR1A 4636/4885MTNR1B 4378/4885L3MBTL1 2847/4885
US-20230303746-A1 PHOTOCURABLE COMPOSITION, DENTURE BASE, AND PLATE DENTURE PARG, SMCHD1, PAM MTNR1A 799/4885MTNR1B 891/4885L3MBTL1 4305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.